Moreover, we determined that MYBL2 promoted the growth of melanoma cells and melanoma stem-like cell proliferation in a mouse model and in melanoma cells, indicating that MYBL2 may be used as a biomarker or therapeutic target. The gene discussed is MYBL2; the disease is melanoma.